Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav

MeSH terms

• Carcinoma, Non-Small-Cell Lung / diagnosis*
• Carcinoma, Non-Small-Cell Lung / therapy*
• Clinical Decision-Making
• Combined Modality Therapy / adverse effects
• Combined Modality Therapy / methods
• Disease Management
• Humans
• Lung Neoplasms / diagnosis*
• Lung Neoplasms / therapy*
• Neoplasm Staging
• Treatment Outcome